General Considerations for the Use of New Approach Methodologies in Drug Development; Guidance for Industry - Draft Guidance
NonrulemakingOtherFDA-2025-D-6131-0002
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Mar 19, 2026
- Agency
- Food and Drug Administration (FDA)